Interaction of n-acetylcysteine and cysteine in human plasma

Journal of Pharmaceutical Sciences

Volumn 101, Issue 12, 2012, Pages 4653-4659

  Radtke, Kendra K ^a   Coles, Lisa D ^a   Mishra, Usha ^a   Orchard, Paul J ^b   Holmay, Mary ^a   Cloyd, James C ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Albumin; Antioxidants; Bioanalysis; HPLC (high performance pressure liquid chromatography); LC MS; Pediatric; Protein binding

Indexed keywords

EID: 84868104105     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.23325     Document Type: Article

References (23)

1. Ventura P, Panini R, Pasini MC, Scarpetta G, Salvioli G. 1999. N-acetyl-cysteine reduces homocysteine plasma levels after single intravenous administration by increasing thiols urinary excretion. Pharmacol Res 40(4):345-350.
2. Bezman L, Moser AB, Raymond GV, Rinaldo P, Watkins PA, Smith KD, Kass NE, Moser HW. 2001. Adrenoleukodystrophy: Incidence, new mutation rate, and results of extended family screening. Ann Neurol 49(4):512-517.
3. Tolar J, Orchard PJ, Bjoraker KJ, Ziegler RS, Shapiro EG, Charnas L. 2007. N-acetyl-l-cysteine improves outcome of advanced cerebral adrenoleukodystrophy. Bone Marrow Transplant 39(4):211-215.
4. Lu JF, Barron-Casella E, Deering R, Heinzer AK, Moser AB, deMesy Bentley KL, Wand GS, MCM, Pei Z, Watkins PA, Pujol A, Smith KD, Powers JM. 2007. The role of peroxisomal ABC transporters in the mouse adrenal gland: The loss of Abcd2 (ALDR), not Abcd1 (ALD), causes oxidative damage. Lab Invest 87(3):261-272.
5. Vargas CR, Wajner M, Sirtori LR, Goulart L, Chiochetta M, Coelho D, Latini A, Llesuy S, Bello-Klein A, Giugliani R, Deon M, Mello CF. 2004. Evidence that oxidative stress is increased in patients with X-linked adrenoleukodystrophy. Biochim Biophys Acta 1688(1):26-32.
6. Miller WP, Rothman SM, Nascene D, Kivisto T, Defor TE, Ziegler RS, Eisengart J, Leiser K, Raymond G, Lund TC, Tolar J, Orchard PJ. 2011. Outcomes following allogeneic hematopoietic cell transplantation for childhood cerebral adrenoleukodystrophy: The largest single-institution cohort report. Blood.
7. Hart AM, Terenghi G, Kellerth JO, Wiberg M. 2004. Sensory neuroprotection, mitochondrial preservation, and therapeutic potential of N-acetyl-cysteine after nerve injury. Neuroscience 125(1):91-101.
8. Raftos JE, Whillier S, Chapman BE, Kuchel PW. 2007. Kinetics of uptake and deacetylation of N-acetylcysteine by human erythrocytes. Int J Biochem Cell Biol 39(9):1698-1706.
9. Cotgreave I, Moldeus P, Schuppe I. 1991. The metabolism of N-acetylcysteine by human endothelial cells. Biochem Pharmacol 42(1):13-16.
10. Whillier S, Raftos JE, Chapman B, Kuchel PW. 2009. Role of N-acetylcysteine and cystine in glutathione synthesis in human erythrocytes. Redox Rep 14(3):115-124.
11. Ohtsuka Y, Kondo T, Kawakami Y. 1988. Oxidative stresses induced the cystine transport activity in human erythrocytes. Biochem Biophys Res Commun 155(1):160-166.
12. Harada D, Anraku M, Fukuda H, Naito S, Harada K, Suenaga A, Otagiri M. 2004. Kinetic studies of covalent binding between N-acetyl-l-cysteine and human serum albumin through a mixed-disulfide using an N-methylpyridinium polymer-based column. Drug Metab Pharmacokinet 19(4):297-302.
13. Harada D, Naito S, Otagiri M. 2002. Kinetic analysis of covalent binding between N-acetyl-l-cysteine and albumin through the formation of mixed disulfides in human and rat serum in vitro. Pharm Res 19(11):1648-1654.
14. Harada D, Naito S, Kawauchi Y, Ishikawa K, Koshitani O, Hiraoka I, Otagiri M. 2001. Determination of reduced, protein-unbound, and total concentrations of N-acetyl-l-cysteine and l-cysteine in rat plasma by postcolumn ligand substitution high-performance liquid chromatography. Anal Biochem 290(2):251-259.
15. Holmay M, Coles L, Mishra U, Basso L, Orchard P, Cloyd J. 2010. Pharmacokinetics of N-acetylcysteine as adjunctive therapy in hematopoietic stem cell transplantation for late-stage childhood cerebral adrenoleukodystrophy. American Society of Clinical Pharmacology and Therapeutics Annual Meeting. Georgia: Atlanta.
16. Bannai S. 1984. Transport of cystine and cysteine in mammalian cells. Biochim Biophys Acta 779(3):289-306.
17. Han D, Handelman G, Marcocci L, Sen CK, Roy S, Kobuchi H, Tritschler HJ, Flohe L, Packer L. 1997. Lipoic acid increases de novo synthesis of cellular glutathione by improving cystine utilization. Biofactors 6(3):321-338.
18. Mills BJ, Lang CA. 1996. Differential distribution of free and bound glutathione and cyst(e)ine in human blood. Biochem Pharmacol 52(3):401-406.
19. King N, Lin H, Suleiman MS. 2011. Oxidative stress increases SNAT1 expression and stimulates cysteine uptake in freshly isolated rat cardiomyocytes. Amino Acids 40(2):517-526.
20. Hong SY, Gil HW, Yang JO, Lee EY, Kim HK, Kim SH, Chung YH, Lee EM, Hwang SK. 2005. Effect of high-dose intravenous N-acetylcysteine on the concentration of plasma sulfur-containing amino acids. Korean J Intern Med 20(3):217-223.
21. Ahola T, Fellman V, Laaksonen R, Laitila J, Lapatto R, Neuvonen PJ, Raivio KO. 1999. Pharmacokinetics of intravenous N-acetylcysteine in pre-term new-born infants. Eur J Clin Pharmacol 55(9):645-650.
22. Magnusson I, Ekman L, Wangdahl M, Wahren J. 1989. N-acetyl-l-tyrosine and N-acetyl-l-cysteine as tyrosine and cysteine precursors during intravenous infusion in humans. Metabolism 38(10):957-961.
23. Banks MF, Stipanuk MH. 1994. The utilization of N-acetylcysteine and 2-oxothiazolidine-4-carboxylate by rat hepatocytes is limited by their rate of uptake and conversion to cysteine. J Nutr 124(3):378-387.